← Russell 3000 cross-section

OWLT Owlet, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-14, not restated
Healthcare

Scale

Market cap
$154m
Revenue TTM
$115m
Net income TTM
$-9m
Free cash flow
$-8m
Composite score
Sector rank
#2952

Valuation

P / E
EV / EBITDA
EV / sales
1.1
FCF yield
-5.53%
Earnings yield vs 10-yr
-10.57pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-7.8%
EBITDA margin
-5.9%
ROE
-38.7%
ROIC
Revenue growth
27.9%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Revenue Recognition The Company generated substantially all of its revenue from the sale of its hardware products, primarily Dream Sock, Dream Sight, and Dream Duo. Revenue allocated to the delivery of the hardware and embedded firmware essential to the functionality of the hardware represent substantially all of the arrangements consideration and reflect the Company’s best estimate of the selling price if it was sold regularly on a stand-alone basis. …Owlet, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-14

Read the full passage →